Insurers, PMBs will be able to negotiate prices for drugs paid by Medicare Part B
The Health and Human Services Secretary Alex Azar said, starting next year Medicare Advantage plans will get new powers to
Read MoreThe Health and Human Services Secretary Alex Azar said, starting next year Medicare Advantage plans will get new powers to
Read More(By Julie Spitzer for Becker’s Hospital Review) Humana filed a lawsuit Aug. 3 against nearly 30 pharmaceutical companies, alleging they united to
Read More(By Orly Nadell Farber for STAT) You’re in recovery from opioid addiction, and your walk to work takes you down
Read More(By Lev Facher for STAT) The Food and Drug Administration on Monday announced a shift in the way it evaluates drugs
Read More(By Megan Thielking for STAT) Calls to U.S. poison control centers about an unapproved antidepressant that has opioid-like effects have
Read More(By Emily Rappleye for Becker’s Hospital Review) A Senate panel tackled administrative spending in healthcare during a hearing July 31, the third
Read More(By Fred Schulte for Kaiser Health News) As Purdue Pharma faced mounting criticism over deaths linked to OxyContin, rival drugmakers
Read MoreAccording to CMS officials, vigorous bidding helped cut the drug plan national average monthly bid amount for 2019 to $51.28,
Read More(By Ed Silverman for STAT) In his first public remarks since rescinding price hikes, Pfizer chief executive officer Ian Read
Read More(By Will Stone for Kaiser Health News) It started with a rolled ankle during a routine Army training exercise. Shannon
Read More